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Objective: Duplex ultrasonography (DU) is the primary method for diagnosis of deep venous thrombosis (DVT) but is
relatively expensive and not always readily available. Attempts to exclude the diagnosis of DVT with D-dimer or clinical
criteria independently have been unsuccessful. The goal of our study was to evaluate a second-generation rapid
quantitative D-dimer and simple clinical parameters for screening of outpatients for DVT.
Patients and Methods: Patients undergoing DU of the lower extremities for suspected DVT were prospectively evaluated.
Patients undergoing lower extremity venous ultrasound scan for suspected pulmonary embolism or already on antico-
agulant therapy were excluded from the study. Data were analyzed to assess the optimal combination of characteristics to
include and exclude proximal DVT.
Results: One hundred fifty-six outpatients met inclusion criteria and were enrolled in the study. Elevated levels of D-dimer
of 0.5 ng/mL or more were noted in 21 of 22 patients diagnosed with DVT, yielding a sensitivity of 95% and negative
predictive value of 99%. Subjective symptoms of swelling or pain were present in 94% of all outpatients. Asymmetric calf
swelling of more than 2.0 cm was noted in 14 of 22 patients (64%) with proximal DVT compared with 22 of 134 patients
(16%) without DVT (P < .003). No single clinical history variable was significant on multivariate analysis. All outpatients
with proximal DVT had either leg swelling of more than 2 cm or a positive D-dimer.
Conclusion: A combination of a second-generation quantitative D-dimer and calf measurement provides an easy and
effective means of excluding proximal DVT when screening outpatients. Patients with calf circumference 2.0 cm or less
and a negative D-dimer may undergo nonemergent DU. Patients with a positive D-dimer or asymmetrical calf swelling
of more than 2.0 cm alone or in combination should undergo emergent DU. (J Vasc Surg 2002;36:877-80.)
Duplex ultrasonography (DU) is the primary method
for diagnosis of deep venous thrombosis (DVT) but is
expensive and time intensive. In addition, most DU per-
formed returns a negative result, with an average of only a
13% to 15% rate of positive examinations in the outpatient
population.1,2
In an attempt to limit the number of DU performed
while maintaining a high rate of sensitivity and negative
predictive value, D-dimer has been used to screen patients
suspected of having DVT. Difficulties in using D-dimer for
excluding DVT include long turnaround time for the sen-
sitive enzyme-linked immunosorbent assay (ELISA) com-
pared with poor sensitivity for the rapid latex and whole
blood agglutination tests.3,4
Other attempts to exclude DVT have included the use
of clinical criteria for risk stratification. Although these
criteria have proven to be valid, physicians have been reluc-
tant to adopt them as the sole method for excluding
DVT.5,6
A new rapid turbidimetric D-dimer with reported
equivalency in sensitivity and specificity to the gold stan-
dard ELISA was recently introduced at the Geisinger Med-
ical Center.7,8 Recent studies have shown that combining
Wells’ risk stratification system with the latex or whole
blood agglutination D-dimer can reliably exclude proximal
DVT in low-risk patient populations with a negative
D-dimer.9-12 We sought to evaluate the results of the
turbidimetric D-dimer in combination with a prospective
evaluation of subjective symptoms, calf circumference, and
objective risk factors to screen patients for DVT.
PATIENTS AND METHODS
The study protocol and informed consent were ap-
proved by the Institutional Review Board before patient
accrual. All patients seen at the vascular laboratory at the
Geisinger Medical Center for evaluation of DVT were
considered eligible. Because study participation was volun-
tary, patient accrual was nonconsecutive. Patients were
excluded if DU was performed for suspicion of pulmonary
embolism, if the patient was taking anticoagulants, if the
patient was pregnant, or if the patient was unable to provide
informed consent.
All patients underwent scanning in our Intersocietal
Commission for the Accreditation of Vascular Laborato-
ries–accredited laboratory per ICAVL protocol. Examina-
tions were conducted with Advanced Technology Labora-
tories Inc (Bothell, Wash) duplex scanners (models
Ultramark 9, Ultramark 9 HDI, or 3000 HDI). Examina-
tions were performed with 5-MHz to 10-MHz linear
probes including grayscale, color flow, and Doppler spec-
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tral scans of the common femoral, deep femoral, superficial
femoral, popliteal, and proximal tibial veins in longitudinal
and transverse planes. In cases of unilateral examinations,
the contralateral common femoral vein was interrogated.
Criteria used to determine the presence or absence of
thrombus included compressibility and intraluminal filling
defects on grayscale scans, spontaneous flow on color
Doppler analysis, and flow characteristics with spectral
analysis.
Chronic DVT was diagnosed with the presence of
thrombus associated with an irregular vein wall, reduced
wall diameter, vein wall thickening, and the presence of
collaterals. Patients with symptoms in only one extremity
did not undergo complete contralateral lower extremity
duplex examination per laboratory protocol.
All patients who participated in the study completed
the duplex scan examination and had a D-dimer drawn
immediately before or after performance of the ultrasound
scan. Patients then completed a health questionnaire con-
sisting of medical history and current health status. Patients
also underwent bilateral calf circumference measurement
10 cm below the patella. Patients were asked to state
subjectively whether they had pain or swelling in either
extremity and, if they did, to state the duration of symp-
toms.
D-dimer analysis was performed with the Liatest D-Di
semiquantitative latex agglutination turbidimetric assay
(Diagnostica Stago, Parsippany, NJ). The assay relies on
the use of a monoclonal antibody specific to D-dimer
fragments as in the latex agglutination test. The reaction is
standardized with photometric analysis of antibody binding
with the Stago Hematest Analyzer (Diagnostica Stago,
Parsippany, NJ), which is then quantitatively reported with
a linear scale in ng/mL. Results are available in approxi-
mately 30 minutes at a cost of $8.00 to the institution. A
level for 0.5 ng/mL or more was considered positive on the
basis of previous studies.7,8
Data were entered and analyzed with Statistical Analy-
sis Systems software (Cary, NC). D-dimer analysis was
compared with the results of DU to calculate sensitivity,
specificity, negative predictive value, and positive predictive
value. To assess the strongest clinical predictors of DVT in
our patient population, the subject’s D-dimer results, calf
circumference, and information from the health question-
naires were analyzed univariately with a two-sample t test,
2 test, or Fisher exact test as appropriate. Furthermore, a
multiple logistic regression analysis was conducted to de-
termine which clinical factors were independently predic-
tive of DVT after controlling for age and gender. All clinical
data and demographics were considered for inclusion in the
model.
RESULTS
A total of 3634 patients was evaluated for DVT from
June 1, 1999 to August 15, 2001, with a DVT rate of
15.7% (n  571). One hundred fifty-six patients who met
inclusion criteria were enrolled in the study. The group
consisted of 99 female and 57 male patients. DVT was
present in 21 patients (14%). Because of the low number of
inpatients accrued, analysis of this group was omitted (n 
24).
D-dimer. Elevated levels of D-dimer of 0.5 ng/mL or
more were noted in 21 of 22 patients with proximal DVT
(median, 2.94 ng/mL; range, 0 to 20.00 ng/mL) and 64
of 156 without proximal DVT (median, 0.49 ng/mL;
range, 0.1 to 11.32 ng/mL; P  .003). The new D-dimer
test alone resulted in a sensitivity of 95% with a specificity of
46% for detecting proximal DVT. The single patient with a
false-negative study was noted to have superficial femoral
and popliteal vein thromboses.
Clinical data. Subjective symptoms of swelling or pain
were present in 146 of 156 outpatients (94%). DVT oc-
curred only in those patients with symptoms of leg pain or
swelling.
A unilateral increase in calf circumference of more than
2 cm was noted in 40 outpatients. Fourteen of 22 patients
(63.6%) with proximal DVT had calf circumference of
more than 2 cm compared with 26 of 134 patients (19.4%)
without DVT (P  .003).
The clinical risk factors examined included previous
DVT, diagnosis of cancer (either active or in remission),
paralysis, trauma to the extremity in last 2 weeks, current
cast on the extremity, bedridden greater than 3 days, major
surgery in last 4 weeks, orthopedic procedure in last 4
weeks, family history of DVT, and estrogen usage (hor-
mone replacement therapy or oral contraceptives). Cancer
was the single clinical risk factor found to be significant on
univariate analysis, but it did not reach statistical signifi-
cance on multivariate analysis. No other risk factors were
significant on univariate analysis (Table I).
D-dimer and calf circumference. On the basis of
multivariate analysis, D-dimer (P  .004) and calf circum-
ference of more than 2 cm (P.023) were both significant
predictors of DVT. On the basis of the new D-dimer alone,
the overall sensitivity was 95% with a negative predictive
value of 98% (Table II). With a combination of D-dimer
and calf circumference of more than 2 cm for evaluation of
outpatients for proximal DVT, the sensitivity and negative
predictive value would be 100%. With exclusion of patients
with a negative D-dimer and calf circumference of 2 cm or
less, 38% of duplex ultrasound scans could be avoided in an
acute care setting. Similarly, 29 of 40 patients (73%) with
calf swelling of more than 2 cm had a D-dimer value of 0.5
ng/mL or more, suggesting that D-dimer analysis in this
group is of no benefit.
DISCUSSION
The use of ultrasound scan to diagnose DVT continues
to gain widespread attention in an attempt to increase the
yield of positive studies and determine the best criteria to
eliminate negative studies. Currently, the rate of positive
studies for DU averages between 13% and 15% in an
outpatient setting, consistent with our rate of 13.3%. Un-
fortunately, no other single noninvasive test to date has
been shown to have the sensitivity and negative predictive
value of a properly performed DU.1,2
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D-dimer or clinical scoring systems have been used in
an attempt to increase the yield of positive DU. Initial
enthusiasm for D-dimer has been tempered by the high rate
of false-positive tests in the inpatient setting and the unac-
ceptable rate of false-negative tests in the outpatient set-
ting.3,4 Recently, the latex agglutination test has under-
gone development into a quantitative turbidimetric assay,
which does not rely on the human eye for interpretation.
Initial results showed equivalent sensitivity for DVT in
comparison with the reference ELISA test (98% to
100%),7,8 with the recognized need for more studies with
greater number of patients to confirm these early findings.
Our study shows a sensitivity of 95% and a negative predic-
tive value of 98% for the new turbidimetric D-dimer in
outpatients for the exclusion of proximal DVT. The test
continues to suffer, however, from a lack of specificity, a
finding common for all D-dimer tests. Despite the high
levels of sensitivity and negative predictive value, many
physicians are reluctant to rely on such a test as the sole
determinant for excluding the diagnosis of DVT.
The use of clinical scoring systems for the stratification
of patients suspected of having DVT is not new. It has been
well documented with various models that patients can be
grouped into high-risk, medium-risk, and low-risk
groups.5,6 The difficulty in utilizing clinical stratification
alone is twofold: 1, the clinical stratification alone is not
sufficient to deny a patient DU as the rate of DVT for
patients classified as low risk is 6% to 8%; and 2, the current
scales may be unwieldy for use in clinical practice.9
In an effort to improve the sensitivity of D-dimer,
studies have addressed the ability to combine D-dimer with
clinical criteria. Recent studies adding Wells’ risk assess-
ment scoring system to the latex agglutination D-dimer
have documented an increase in sensitivity to more than
98% for proximal DVT in those patients at low risk with a
D-dimer less than 0.5 ng/mL.9-12 Most importantly, these
studies have shown the ability of a negative D-dimer with a
low clinical probability of DVT to reliably exclude proximal
DVT in an outpatient population (Table III). Our study
also confirms the ability of clinical variables to enhance the
sensitivity of D-dimer.
Although the sensitivity of D-dimer alone in our study
was 95% for proximal DVT in outpatients, with the addi-
tion of calf circumference, the sensitivity increases to 100%.
The combination of D-dimer and calf circumference would
allow us to eliminate approximately 40% of all DU in the
acute setting if those patients with a negative D-dimer and
calf circumference less than 2 cm were excluded. Similarly,
utilization of D-dimer could be enhanced by proceeding
directly to DU for patients with calf circumference more
than 2 cm because approximately 75% of these patients will
have a positive D-dimer. Our study complements the re-
cent studies that suggested that a combination of D-dimer
with clinical variables may be the ideal method for selection
of patients suspected of having proximal DVT (Table
III).9-12 In contrast, the evaluation of calf vein DVT has
not shown equivalent results with D-dimer and clinical
variables in combination.9,10
As compared with previous studies that have used the
risk assessment strategy of Wells to exclude proximal DVT,
our study sought to identify simple objective clinical pre-
dictors already known to be risk factors for DVT to aid in
the evaluation of patients with DVT. The most commonly
used risk assessment system that has been used has been
criticized as being difficult to implement in clinical prac-
tice.11 Our study showed a high level of sensitivity for
D-dimer to exclude proximal DVT. With the addition of a
single significant clinical variable, the ability to accurately
exclude proximal DVT is attainable. In contrast to Wells’
criteria,5,6 which requires subjective clinical evaluation (al-
ternative diagnosis, dilated superficial veins, erythema of
the symptomatic limb) and a calculation of specific scores,
our study relies solely on D-dimer analysis and calf circum-
ference measurement to exclude DVT. It is our feeling that
this system is easy to use and able to be performed expedi-
tiously in an outpatient setting.
Table I. Univariate analysis of demographics, physical
findings, and clinical risk factors for DVT
DVT
(n  21)
No DVT
(n  135) P value
Age (y), mean (standard
deviation)
62.2 (16.6) 59.3 (16.1) .44*
Male gender 12 (57%) 45 (33%) .035†
Any pain 16 (76%) 102 (76%) .95†
Any swelling 20 (95%) 100 (74%) .047‡
Any pain or swelling 21 (100%) 125 (93%) .36‡
Difference in calf
circumference  2 cm
14 (67%) 42 (31%) .002†
D-dimer  0.5 20 (95%) 64 (47%) .001‡
Previous DVT 6 (29%) 23 (17%) .23‡
Diagnosis of cancer 5 (24%) 10 (7%) .03‡
Paralysis 0 1 (1%) .99‡
Trauma to extremity in last 2
weeks
1 (5%) 15 (11%) .70‡
Current cast on extremity 0 2 (1%) .99‡
Bedridden 3 days 0 8 (6%) .60‡
Major surgery in last 4 weeks 1 (5%) 12 (9%) .99‡
Orthopedic procedure in last
4 weeks
1 (5%) 8 (6%) .99‡
Family history of DVT 1 (5%) 13 (10%) .69‡
Estrogen use 2 (10%) 28 (21%) .37‡
*Two-sample t test.
†2 test.
‡Fisher exact test.
Table II. Results of D-dimer analysis in evaluation of
proximal DVT in outpatients
Outpatients
(n  156)
DVT
Present Absent
D-dimer
Positive (0.5) 21 62
Negative (0.5) 1 72
Sensitivity, 95%; specificity, 46%; negative predictive value, 98%; positive
predictive value, 25%.
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Several limitations of the study deserve mention. First,
the inpatient population was small and therefore was
excluded from further analysis. Because the purpose of
the study was to evaluate patients suspected of having
proximal DVT in need of emergent DU,13-16 we did not
seek to evaluate every patient with bilateral duplex scan
evaluation or serial ultrasound scans or include complete
calf vein evaluation. Because this study sought to evalu-
ate a new D-dimer in combination with clinical criteria in
the setting of standard practice, our routine evaluation of
patients was not altered. Lastly, our study included only
patients willing to participate, and therefore our results
may be biased because this was not a consecutive series of
patients.
CONCLUSION
A combination of D-dimer and calf circumference pro-
vides an easy and effective means of excluding DVT in
patients suspected of having proximal DVT. A combination
of D-dimer less than 0.5 ng/mL and calf circumference of
2 cm or less reliably excludes DVT in the acute setting and
allows for use of DU in a nonemergent setting. Patients
with a positive D-dimer or calf circumference of more than
2 cm require emergent DU to exclude DVT.
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Table III. Sensitivity of D-dimer alone and in combination with calf circumference for evaluation of proximal DVT
Author Clinical prediction model Patient population
Sensitivity
D-dimer alone
Sensitivity
D-dimer and clinical
criteria
Johanning et al Calf circumference Outpatient 95% 100%
Dryjski et al Wells Outpatient 80% 100% (Wells)
Lennox et al Wells Outpatient and Inpatient 100% 100% (Wells)
Aschwanden et al Wells Outpatient and Inpatient 89% 98% (Wells)
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